A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein
Overview
Affiliations
Rabies is a highly prevalent zoonotic disease and a public health threat worldwide. Currently licensed rabies vaccines are effective but less is known which would protect cattle. This study describes the construction of a novel recombinant bovine herpes virus type I (BHV-1) expressing rabies virus glycoprotein (RABV G) instead of its gE glycoprotein (gE) by CRISPR-Cas9 and homologous recombination technology (BHV-1-ΔgE-G). Insertion of the RABV G gene is stable after 20 rounds of passaging and the recombinant virus replicates to high titers in MDBK cells. The RABV G expresses in the recombinant virus-infected cells and on the virion surface of BHV-1-ΔgE-G. One single immunization with BHV-1-ΔgE-G-activated dendritic cells (DCs) and B cells furthermore induced a protective immune response in mice against severe lethal challenge infection. A protective level of RABV-specific virus-neutralizing antibody (VNA) was detected in intramuscular immunized mice and cattle without any clinical symptoms. This research demonstrated that the BHV-1 vector-based RABV vaccine is a potential candidate for cattle.
Ren B, Qin H, Zhang Y, Du X, Sun H, Luo Y Virulence. 2024; 16(1):2445235.
PMID: 39727074 PMC: 11702956. DOI: 10.1080/21505594.2024.2445235.
Murr M, Freuling C, Perez-Bravo D, Grund C, Mettenleiter T, Romer-Oberdorfer A PLoS Negl Trop Dis. 2024; 18(2):e0011639.
PMID: 38408125 PMC: 10919857. DOI: 10.1371/journal.pntd.0011639.
Application of CRISPR/Cas9 for Rapid Genome Editing of Pseudorabies Virus and Bovine Herpesvirus-1.
Yu W, Liu J, Liu Y, Forlenza M, Chen H Viruses. 2024; 16(2).
PMID: 38400086 PMC: 10892916. DOI: 10.3390/v16020311.
An mRNA vaccine against rabies provides strong and durable protection in mice.
Li M, Fang E, Wang Y, Shi L, Li J, Peng Q Front Immunol. 2023; 14:1288879.
PMID: 37954577 PMC: 10639119. DOI: 10.3389/fimmu.2023.1288879.
Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of Immunization.
Natesan K, Isloor S, Vinayagamurthy B, Ramakrishnaiah S, Doddamane R, Fooks A Vaccines (Basel). 2023; 11(4).
PMID: 37112668 PMC: 10147034. DOI: 10.3390/vaccines11040756.